In this article we are going to estimate the intrinsic value of Organogenesis Holdings Inc. (NASDAQ:ORGO) by taking...
Organogenesis (NASDAQ:ORGO) was downgraded by BidaskClub from a “sell” rating to a “strong sell” rating in a research report issued to clients and investors on Wednesday, BidAskClub reports. O
Organogenesis Holdings has been struggling lately, but the selling pressure may be coming to an end soon.
Organogenesis Holdings has been struggling lately, but the selling pressure may be coming to an end soon.
Organogenesis Holdings Inc (NASDAQ:ORGO) was the recipient of a large growth in short interest in the month of March. As of March 13th, there was short interest totalling 169,300 shares, a growth of 4
The cannabis space has seen a string of layoffs, and some companies are resorting to temporary hiring. Liesl Bernard, the founder and CEO of cannabis staffing firm...
Organogenesis Holdings Inc. (ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical
State Street Corp lifted its position in shares of Organogenesis Holdings Inc (NASDAQ:ORGO) by 30.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commis
Barclays PLC lifted its stake in Organogenesis Holdings Inc (NASDAQ:ORGO) by 214.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned
Charles Schwab Investment Management Inc. boosted its holdings in Organogenesis Holdings Inc (NASDAQ:ORGO) by 97.7% during the 4th quarter, according to its most recent disclosure with the Securities
Organogenesis (NASDAQ: ORGO) is one of 605 public companies in the “Pharmaceutical preparations” industry, but how does it contrast to its competitors? We will compare Organogenesis to similar com

Analyzing Organogenesis (ORGO) & The Competition

07:06am, Thursday, 19'th Mar 2020
Organogenesis (NASDAQ: ORGO) is one of 605 public companies in the “Pharmaceutical preparations” industry, but how does it weigh in compared to its rivals? We will compare Organogenesis to similar
Bank of Montreal Can boosted its position in Organogenesis Holdings Inc (NASDAQ:ORGO) by 12,569.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The
Organogenesis (NASDAQ: ORGO) is one of 605 public companies in the “Pharmaceutical preparations” industry, but how does it contrast to its peers? We will compare Organogenesis to similar businesse

Organogenesis (NASDAQ:ORGO) Upgraded at BidaskClub

07:48am, Wednesday, 18'th Mar 2020
Organogenesis (NASDAQ:ORGO) was upgraded by investment analysts at BidaskClub from a “strong sell” rating to a “sell” rating in a research note issued to investors on Wednesday, BidAskClub rep
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE